期刊文献+

一株海洋放线菌次级代谢产物的抗肿瘤活性研究 被引量:2

Inhibitory effect of the secondary metabolities from a marine-derived strain against human cancer cells
下载PDF
导出
摘要 目的对一株南海深海海洋沉积物来源放线菌SCSIO 11594分离出的5个天然次级代谢产物进行初步的抗肿瘤活性研究。方法将5个天然次级代谢产物命名为化合物1~5,通过CCK8细胞毒性试验检测化合物作用于5株肿瘤细胞及1株正常肝脏细胞HL-7702后的效果,通过Graphad prism软件测定其IC50,并与经典抗肿瘤药物顺铂对比。结果顺铂作用于5株肿瘤细胞的IC50值范围3.75~5.32μmol/L,化合物2作用于5株肿瘤细胞的IC50值范围0.24~0.74μmol/L,对肿瘤细胞的抑制作用是顺铂的10~20倍;化合物4作用于5株肿瘤细胞的IC50值范围0.28~6.93μmol/L,对肿瘤细胞的抑制作用是顺铂的1~10倍;化合物2和4作用于正常肝脏细胞HL-7702的IC50值分别为3.67μmol/L和12.47μmol/L,与作用于肿瘤细胞的IC50值相比,提示具有较好的抗肿瘤选择性。结论放线菌SCSIO 11594分离出的次级代谢产物2和4具有较好的抗肿瘤活性和选择性,具有潜在的开发前景。 Objective To study the antineoplastic activity of five secondary metabolites from Streptomyces sp.SCSIO 11594 which is isolated from the south deep-sea sediment. Methods Five secondary metabolites from Streptomyces sp. SCSIO 11594 were named compound 1~5. CCK8 cytotoxicity was applied to evaluate the antineoplastic activity of compound 1~5 on five tumor cell lines and a normal human liver cell line HL7702. Half maximal inhibitory concentration(IC50) was detected through Graphad prism and then compared with that of the classical antitumor drug Cisplatin.Results IC50 values of Ciplatin against five tumor cell lines were in the range of 3.76~5.32 μ mol/L. IC50 values of Compound 2 against five tumor cell lines ranged from 0.24~0.74 μmol/L, which was 10~20-fold more cytotoxic than the positive control Cisplatin. IC50 values of Compound 4 against five tumor cell lines ranged from 0.28~6.93 μmol/L, which was 1~10-fold more cytotoxic than Cisplatin. IC50 values of Compound 2 and Compound 4 against normal human liver cell line HL7702 were 3.67 μmol/L and 12.47 μmol/L. The results demonstrated that Compound 2 and Compound 4 had good cytotoxic selectivity. Conclusion Two secondary metabolites from Streptomyces sp. SCSIO 11594(Compound 2and Compound 4) have good antitumor activity and cytotoxic selectivity, which own a good development prospect.
出处 《海南医学》 CAS 2016年第8期1205-1207,共3页 Hainan Medical Journal
基金 国家自然科学基金(编号:81300398) 广东省扬帆计划[编号:粤人才办(2014)1]
关键词 海洋放线菌 次级代谢产物 抗肿瘤活性 Marine Actinomycetes Secondary metabolites Antitumor activity
  • 相关文献

参考文献16

  • 1BLUNT J W,COPP B R,KEYZERS R A,et al.Marine natural products. Natural Product Reports . 2013
  • 2Xiong ZQ,Wang JF,Hao YY.Recent advances in the discovery and development ofmarine microbial natural products. Mar.Drugs . 2013
  • 3Adinarayana Gorajana,Venkatesan M,Saisha Vinjamuri,Bapiraju V.V.S.N. Kurada,Sujatha Peela,Premkumar Jangam,Ellaiah Poluri,Axel Zeeck.??Resistoflavine, cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN 1 /7(J)Microbiological Research . 2006 (4)
  • 4Sung-Hwan Eom,Young-Mog Kim,Se-Kwon Kim.??Marine bacteria: potential sources for compounds to overcome antibiotic resistance(J)Applied Microbiology and Biotechnology . 2013 (11)
  • 5Randy Chi Fai Cheung,Jack Ho Wong,Wen Liang Pan,Yau Sang Chan,Cui Ming Yin,Xiu Li Dan,He Xiang Wang,Evandro Fei Fang,Sze Kwan Lam,Patrick Hung Kui Ngai,Li Xin Xia,Fang Liu,Xiu Yun Ye,Guo Qing Zhang,Qing Hong Liu,Ou Sha,Peng Lin,Chan Ki,Adnan A Bekhit,Alaa El-Din Bekhit,David Chi Cheong Wan,Xiu Juan Ye,Jiang Xia,Tzi Bun Ng.Antifungal and antiviral products of marine organisms[J]. Applied Microbiology and Biotechnology . 2014 (8)
  • 6曾艳霞,刘玮炜.抗肿瘤海洋药物研究新进展[J].化工时刊,2006,20(8):68-70. 被引量:2
  • 7王长云,邵长伦,傅秀梅,兰东,兰克信,李国强,武云飞,钱树本,管华诗.中国海洋药物资源及其药用研究调查[J].中国海洋大学学报(自然科学版),2009,39(4):669-675. 被引量:33
  • 8Takeshi Yamada,Katsuhiko Minoura,Atsushi Numata.??Halichoblelide, a potent cytotoxic macrolide from a Streptomyces species separated from a marine fish(J)Tetrahedron Letters . 2002 (9)
  • 9Michael C. Edler,Annette M. Fernandez,Peter Lassota,Chris M. Ireland,Louis R. Barrows.??Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10(J)Biochemical Pharmacology . 2002 (4)
  • 10TF Molinski,DS Dalisay,SL Lievens,JP Saludes.Drug development from marine natural products. Nature reviews. Drug discovery . 2009

二级参考文献17

  • 1陈冀胜.海洋生物活性物质研究概况及展望[J].中国海洋药物,1993,12(1):18-26. 被引量:14
  • 2王长云,耿美玉,管华诗.海洋药物研究进展与发展趋势[J].中国新药杂志,2005,14(3):278-282. 被引量:17
  • 3王晨,吴志纯.我国药用生物资源开发利用的调查[J].中国科学院院刊,1996,11(6):423-429. 被引量:3
  • 4粱玉波,马明辉,王长云,等.海洋生物生态调查技术规程[M].北京:海洋出版社.2006.
  • 5Zhang W, Guo Y W, Gu Y C. Secondary metabolites from the South China Sea invertebrates: chemistry and biological activity [J]. Current Med Chem, 2006, 13: 2041-2090.
  • 6Wu J, Xiao Q, Xu J, et al. Natural products from true mangrove flora: source, chemistry and bioactivities [J]. Nat Prod Rep, 2008, 25: 955-981.
  • 7Li M Y, Xiao Q, Pan J Y, et al. Natural products from semi-mangrove flora: source, chemistry and bioactivities [ J ]. Nat Prod Rep, 2009, 26: 281-298.
  • 8Faye F.Science,1994,266:1324
  • 9Pettit G R,et al.J Amer Chem Soc,1984,106,6768~6771
  • 10Pettit G R,Kamano Y.J Nat Prod,1981,44(4):482~485

共引文献34

同被引文献42

引证文献2

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部